The Russian resident company Skolkovo has registered the first domestic device for marking tumor foci. Developed by Oncolynn to reduce labeling costs.
The first domestic device for marking tumor foci was registered in RussiaKirill Bilyk
The press service of Skolkovo told about the receipt of the registration certificate by Oncolinn RB. The company has already received Russian and Eurasian patents.
The localizer needle visualizes the tumor bed during and after preoperative systemic therapy. The product includes three markers at once, which will allow you to refuse to use three foreign products with one marker. With Oncolynn’s development, it is possible to label tumors and, if necessary, lymph nodes, for example, in the treatment of breast cancer.
The Skolkovo press service noted that the Oncolynn product can completely replace imported analogues in the Russian and foreign markets.
Oncolinn is negotiating with investors to organize serial production of products to provide them to oncological hospitals in Russia.
Cover photo: metamorworks /
Subscribe to our Telegram channelto keep up to date with the latest news and events!
Source: RB.RU by rb.ru.
*The article has been translated based on the content of RB.RU by rb.ru. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!